Biotech companies Conexeu Sciences, Vor Bio, Cabaletta Bio, and Jade Biosciences announced plans to participate in a string of September–October 2026 investor conferences, including management presentations, one-on-one meetings, and webcasted fireside chats across major events such as Wells Fargo, Citi, Morgan Stanley, Cantor, and others. The companies emphasize investor engagement and webcast availability as they push forward their autoimmune disease programs and tissue-restoration platforms.